OverviewChartNewsTraderScreen

UC TUR.WAR.OP.END. N0XA/  DE000HD4JB24  /

gettex
14/06/2024  19:46:06 Chg.-0.1900 Bid20:58:31 Ask20:58:31 Underlying Strike price Expiration date Option type
1.5000EUR -11.24% 1.4800
Bid Size: 3,000		 1.5100
Ask Size: 3,000		 NEXI 4.2589 - 31/12/2078 Call
GlobeNewswire 12/06 Worthington Enterprises Schedules Fourth Quarter 2024 Earnings Call for June 26
GlobeNewswire 03/06 Worthington Enterprises Completes Acquisition of Hexagon Ragasco
GlobeNewswire 24/10/2023 NexImmune, Yale, and JDRF Extend Research Partnership for Type 1 Diabetes
GlobeNewswire 19/10/2023 NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting
GlobeNewswire 18/10/2023 NexImmune Announces 1-for-25 Reverse Stock Split
GlobeNewswire 29/09/2023 Calian Launches Digital Health Portfolio of Products and Services
GlobeNewswire 28/09/2023 Northland Power Announces Financial Close of the 1.0 GW Hai Long Offshore Wind Project in Taiwan Fin...
GlobeNewswire 31/08/2023 NexImmune Announces Workforce Reduction to Enable Continued AIMTM Nanoparticle Platform Development ...
GlobeNewswire 17/03/2022 NexImmune and Zephyr AI Announce a Strategic Partnership in Oncology for Target Discovery and Valida...
GlobeNewswire 14/03/2022 NexImmune Announces Melanoma Research Collaboration with NYU Langone’s Perlmutter Cancer Center
GlobeNewswire 10/03/2022 NexImmune to Present at the Barclays 2022 Global Healthcare Conference
GlobeNewswire 09/03/2022 NexImmune Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
GlobeNewswire 17/02/2022 NexImmune Appoints Kristi Jones as Chief Executive Officer and Member of the Board of Directors
GlobeNewswire 05/01/2022 NexImmune Announces Formation of Autoimmune and Infectious Diseases Scientific Advisory Board
GlobeNewswire 12/12/2021 NexImmune Announces Preliminary Phase 1/2 NEXI-002 Results in Patients with Multiple Myeloma
GlobeNewswire 12/11/2021 NexImmune Reports Third Quarter 2021 Financial Results and Provides Business Updates
GlobeNewswire 08/11/2021 NexImmune to Announce Third Quarter 2021 Financial Results and Provide Corporate Update on November ...
GlobeNewswire 03/11/2021 NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting
GlobeNewswire 20/10/2021 Bottomline Appoints Three New Directors to Board of Directors
GlobeNewswire 27/09/2021 NexImmune to Present at the 2021 Cantor Virtual Global Healthcare Conference
GlobeNewswire 16/09/2021 SBM Offshore completes US$1.6 billion financing of Sepetiba
GlobeNewswire 10/09/2021 NexImmune to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
GlobeNewswire 18/08/2021 Aite-Novarica Group Announces Winners of the 2021 Digital Wallet Innovation Awards
GlobeNewswire 09/08/2021 NexImmune Reports Second Quarter 2021 Financial Results and Provides Business Updates
GlobeNewswire 09/08/2021 NexImmune to Explore the Use of AIM™ Direct Injection Technology in Type 1 Diabetes